|[April 29, 2014]
Research and Markets: Global Nanomedicine Market Forecasts Report 2013-2019
DUBLIN --(Business Wire)--
Research and Markets (http://www.researchandmarkets.com/research/t6tzdf/nanomedicine)
has announced the addition of the "Nanomedicine
Market - Global Industry Analysis, Size, Share,Growth, Trends and
Forecast, 2013 - 2019" report to their offering.
The emergence of nanomedicine and the application of nanomaterials in
the healthcare industry will bring about groundbreaking improvements to
the current therapeutic and diagnostic scenario. Some of the drivers of
this market include increasing research funding, rising government
support, improved regulatory framework, technological know-how and
rising prevalence of chronic diseases such as diabetes, cancers,
obesity, kidney disorders, orthopedic diseases and others.
The global nanomedicine market is categorized into six segments on the
basis of application, namely neurology, cardiovascular,
anti-inflammatory, anti-infective, oncology and others.
Oncology held majority of the market share in 2012 on account of
Presence of high number of commercialized nanomedicine products in the
Improved bioavailability and efficacy of the tumor specific
nanomedicine enabling targeted drug delivery
However, the global market for cardiovascular segment is expected to
grow at the fastest pace owing to increasing prevalence of
cardiovascular diseases demanding drugs with improved efficacy and
therapeutic properties. Furthermore, realizing the importance and
benefits of nanomedicine, researchers and manufacturers are striving to
develop products with improved therapeutic properties in the
The North American nanomedicine market held the majority of global
market share in 2012 because of the rapidly growing nanomedicine market
in the Asia-Pacific, Latin American and African region, presence of
large number of patented nanomedicine products and favorable regulatory
framework in the region.In addition, the presence of sophisticated
healthcare infrastructure supports development of advanced products such
as nano probes, nanorobots, monoclonal antibody based immunoassays and
nanoparticle based imaging agents for early detection of diseases.
However, the Asia-Pacific region is expected to grow at a faster CAGR
owing to presence of high unmet healthcare needs, research
collaborations and increase in nanomedicine research funding in emerging
economies such as China, India and other economies in the region. China
is expected to surpass the United States in terms of nanotechnology
funding in the near future, which indicates the growth offered by this
The global nanomedicine market is categorized into the following
Key Topics Covered:
Chapter 1 Preface
Chapter 2 Executive Summary
Chapter 3 Global Nanomedicine Market Overview
Chapter 4 Global Nanomedicine Market, by Applications
Chapter 5 Global Nanomedicine Market, by Geography
Chapter 6 Recommendations
Chapter 7 Company Profiles
Johnson & Johnson
Merck & Company Inc.
Sigma-Tau Pharmaceuticals Inc.
Teva Pharmaceutical Industries Ltd.
For more information visit http://www.researchandmarkets.com/research/t6tzdf/nanomedicine
[ Back To TMCnet.com's Homepage ]